- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01892267
Self-Propelled Versus Standard Percutaneous Endoscopic Gastrojejunostomy(PEG-J); RCT
April 13, 2017 updated by: Mouen Khashab, Johns Hopkins University
Comparison Outcomes and Complications of Self-Propelled vs. Standard Percutaneous Endoscopic Gastrojejunostomy (PEG-J); a Randomized Single Blind Clinical Trial
Our main hypothesis is that self-propelled Percutaneous Endoscopic Gastrojejunostomy tube (PEG-J) that has a balloon on it's tip is associated with lower J-tube retrograde migration rate, and lower rates of short- and long-term complications when compared to standard PEGJ feeding tubes.
Study Overview
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 76 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Consecutive adult patients (18-80 years of age) with need for post-pyloric feeding (patients unable to eat due to stroke, intubated patients with respiratory failure, patients with acute pancreatitis, etc).
- Ability to give informed consent.
Exclusion Criteria:
- Unable to give informed consent
- Pregnant or breastfeeding women (all women of child-bearing age will undergo urine pregnancy testing)
- Acute gastrointestinal bleeding
- Coagulopathy defined by prothrombin time < 50% of control; PTT > 50 sec, or INR > 1.5), on chronic anticoagulation, or platelet count <50,000
- Inability to tolerate sedated upper endoscopy due to cardio-pulmonary instability or other contraindication to endoscopy
- Cirrhosis with portal hypertension, varices, and/or ascites
- Allergy to egg
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Self-propelled PEGJ feeding tube
Patients in this arm will receive self-propelled balloon PEGJ tube.
|
PEG-J placement
|
|
Active Comparator: Standard PEGJ feeding tube
Patients in this arm will receive the standard commercially availabel PEGJ tube.
|
PEG-J placement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With PEG-J Tube Migration
Time Frame: From date of placement up to 4 weeks
|
Number of participants in whom migration was assessed by X-ray at 4 weeks post-intervention.
|
From date of placement up to 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Repeat Endoscopy for Feeding Tube Placement Due to Retrograde Tube Migration
Time Frame: 4 weeks
|
Patiens who will have retrograde PEG-J tube migration will get repeat endoscopy for PEG-J tube placement
|
4 weeks
|
|
Patency of Feeding Tube
Time Frame: 2 years
|
Determine tube patency which is defined as time period between tube placement and need for re-intervention.
|
2 years
|
|
Technical Success
Time Frame: Intra-procedural
|
Success of tube placement in the desired location as determined endoscopically.
|
Intra-procedural
|
|
Intervention Time
Time Frame: Intra-procedural
|
Time required from introduction of the upper endoscope until placement of the feeding tube.
|
Intra-procedural
|
|
Time to Repeat Endoscopy for Tube Replacement
Time Frame: 2 years
|
If repeate endocopy and tube placement are needed due to clogging or retrograde migration
|
2 years
|
|
Difficulty of the Procedure
Time Frame: Inra-procedural
|
Scored by the endoscopist on a 10-point Visual Analogue Scale with zero being "without difficulty" and 10 being "maximum difficulty". The lower the score, the better the outcome. |
Inra-procedural
|
|
Gastrointestinal Quality of Life Index (GIQLI) Score
Time Frame: 3 month
|
Gastrointestinal Quality of Life Index (GIQLI) score ranging from 0 (worst quality of life possible with severe digestive symptoms) to 144 (optimal quality of life without symptoms
|
3 month
|
|
Short-term Complications
Time Frame: One week
|
Short-term complications will include stomal (Infection, erythema, bleeding, pain and secretion, etc) and tube (Clotting, dislocation, defect, aspiration, etc) complications detected in the first week.
|
One week
|
|
Long-term Complications
Time Frame: 2 years
|
Long-term complications will include stomal (Infection, erythema, bleeding, pain, secretion, abscess, etc) and tube (Clotting, dislocation, defect and aspiration, etc) complications detected more than one week after intervention.
|
2 years
|
|
Direct Cost
Time Frame: 2 years
|
Cost will be determined according to Medicare reimbursement of billed CPT codes.
The cost of all related follow-up procedures will be included (e.g.
cost of standard PEGJ in case of failed Self-propelled PEGJ feeding tube, cost of managing complications, cost of re-intervention in case of tube dysfunction, etc)
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mouen Khashab, MD, Johns Hopkins Hospital Department of Gastroenterology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 6, 2013
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
July 1, 2013
First Submitted That Met QC Criteria
July 3, 2013
First Posted (Estimate)
July 4, 2013
Study Record Updates
Last Update Posted (Actual)
May 17, 2017
Last Update Submitted That Met QC Criteria
April 13, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NA_00079056
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.